| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | CORTACTIN | 3.50e-05 | 2 | 111 | 2 | PS51090 | |
| Domain | DUF1712 | 3.50e-05 | 2 | 111 | 2 | PF08217 | |
| Domain | HS1_rep | 3.50e-05 | 2 | 111 | 2 | PF02218 | |
| Domain | Hs1_Cortactin | 3.50e-05 | 2 | 111 | 2 | IPR003134 | |
| Domain | DUF1712_fun | 3.50e-05 | 2 | 111 | 2 | IPR013176 | |
| Domain | HATPase_c | 1.85e-04 | 19 | 111 | 3 | PF02518 | |
| Domain | Lipase_panc | 2.08e-04 | 4 | 111 | 2 | IPR002331 | |
| Domain | - | 2.16e-04 | 20 | 111 | 3 | 3.30.565.10 | |
| Domain | HATPase_C | 2.51e-04 | 21 | 111 | 3 | IPR003594 | |
| Domain | HELP | 5.17e-04 | 6 | 111 | 2 | PF03451 | |
| Domain | HELP | 5.17e-04 | 6 | 111 | 2 | IPR005108 | |
| Domain | WxxW_domain | 5.17e-04 | 6 | 111 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 5.17e-04 | 6 | 111 | 2 | PF13330 | |
| Domain | Lipase/vitellogenin | 1.53e-03 | 10 | 111 | 2 | IPR013818 | |
| Domain | TAG_lipase | 1.53e-03 | 10 | 111 | 2 | IPR000734 | |
| Domain | Lipase | 1.53e-03 | 10 | 111 | 2 | PF00151 | |
| Domain | Lipase_N | 1.53e-03 | 10 | 111 | 2 | IPR033906 | |
| Domain | Lipase_LIPH | 1.53e-03 | 10 | 111 | 2 | IPR016272 | |
| Domain | Kinesin-like_fam | 2.12e-03 | 43 | 111 | 3 | IPR027640 | |
| Domain | - | 2.27e-03 | 44 | 111 | 3 | 3.40.850.10 | |
| Domain | Kinesin | 2.27e-03 | 44 | 111 | 3 | PF00225 | |
| Domain | KISc | 2.27e-03 | 44 | 111 | 3 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 2.27e-03 | 44 | 111 | 3 | PS00411 | |
| Domain | Kinesin_motor_dom | 2.27e-03 | 44 | 111 | 3 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 2.27e-03 | 44 | 111 | 3 | PS50067 | |
| Domain | ATPase_dyneun-rel_AAA | 3.04e-03 | 14 | 111 | 2 | IPR011704 | |
| Domain | AAA_5 | 3.04e-03 | 14 | 111 | 2 | PF07728 | |
| Domain | p53-like_TF_DNA-bd | 3.86e-03 | 53 | 111 | 3 | IPR008967 | |
| Domain | Quinoprotein_ADH-like_supfam | 3.86e-03 | 53 | 111 | 3 | IPR011047 | |
| Domain | Sulfatase_CS | 3.98e-03 | 16 | 111 | 2 | IPR024607 | |
| Domain | Gal_mutarotase_SF_dom | 4.49e-03 | 17 | 111 | 2 | IPR011013 | |
| Domain | TF_T-box | 4.49e-03 | 17 | 111 | 2 | IPR001699 | |
| Domain | SULFATASE_1 | 4.49e-03 | 17 | 111 | 2 | PS00523 | |
| Domain | Kringle_CS | 4.49e-03 | 17 | 111 | 2 | IPR018056 | |
| Domain | KRINGLE_1 | 4.49e-03 | 17 | 111 | 2 | PS00021 | |
| Domain | KR | 4.49e-03 | 17 | 111 | 2 | SM00130 | |
| Domain | Kringle | 4.49e-03 | 17 | 111 | 2 | IPR000001 | |
| Domain | TBOX | 4.49e-03 | 17 | 111 | 2 | SM00425 | |
| Domain | TF_T-box_CS | 4.49e-03 | 17 | 111 | 2 | IPR018186 | |
| Domain | - | 4.49e-03 | 17 | 111 | 2 | 2.60.40.820 | |
| Domain | KRINGLE_2 | 4.49e-03 | 17 | 111 | 2 | PS50070 | |
| Domain | TBOX_3 | 4.49e-03 | 17 | 111 | 2 | PS50252 | |
| Domain | Kringle | 4.49e-03 | 17 | 111 | 2 | PF00051 | |
| Domain | T-box | 4.49e-03 | 17 | 111 | 2 | PF00907 | |
| Domain | SULFATASE_2 | 4.49e-03 | 17 | 111 | 2 | PS00149 | |
| Domain | TBOX_1 | 4.49e-03 | 17 | 111 | 2 | PS01283 | |
| Domain | TBOX_2 | 4.49e-03 | 17 | 111 | 2 | PS01264 | |
| Domain | Sulfatase | 5.03e-03 | 18 | 111 | 2 | PF00884 | |
| Domain | LH2 | 5.03e-03 | 18 | 111 | 2 | SM00308 | |
| Domain | - | 5.03e-03 | 18 | 111 | 2 | 3.30.470.20 | |
| Domain | HATPase_c | 5.03e-03 | 18 | 111 | 2 | SM00387 | |
| Domain | Sulfatase_N | 5.03e-03 | 18 | 111 | 2 | IPR000917 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | WDR36 BCLAF1 FBRS MED1 DNAJC10 NAT10 ZBTB10 RBM6 CTTN TOP2B TRMT61A | 1.79e-07 | 440 | 111 | 11 | 34244565 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | RTCB VWA8 BCLAF1 EWSR1 MED1 NSD3 SULF2 GANAB DNAJC10 NRXN2 MAMDC2 NAT10 RBM6 TNXB TOP2B | 1.88e-06 | 1082 | 111 | 15 | 38697112 |
| Pubmed | VWA8 FBRS ISY1 NSD3 MLH3 SULF2 EML5 DNAJC10 ZNF608 SETD5 NAT10 ZBTB10 ZFHX3 KAT6B MGA | 2.75e-06 | 1116 | 111 | 15 | 31753913 | |
| Pubmed | WDR36 RTCB EWSR1 MED1 KIF24 ISY1 GANAB NAT10 RBM6 SPATS2 CTTN KIF22 | 3.59e-06 | 723 | 111 | 12 | 34133714 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 3.73e-06 | 283 | 111 | 8 | 30585729 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 7.20e-06 | 411 | 111 | 9 | 35182466 | |
| Pubmed | CCZ1B MAP2K4 NRDC FBRS STAT6 NLGN3 MLF2 EML5 CCZ1 SETD5 NAT10 ZBTB10 MGA TNS1 | 9.52e-06 | 1084 | 111 | 14 | 11544199 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 21646305 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 21669400 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 36098904 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 15710041 | ||
| Pubmed | Cortactin as a target for FAK in the regulation of focal adhesion dynamics. | 1.01e-05 | 2 | 111 | 2 | 22952866 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 15225882 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | WDR36 RTCB ACLY OAT SRPRA EWSR1 MLF2 GANAB LMAN1 DHFR NAT10 MORC3 TOP2B SDF2 KIF22 | 1.98e-05 | 1318 | 111 | 15 | 30463901 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | BCLAF1 ACLY SRPRA MED1 PTK2 ISY1 NAT10 SPATS2 CTTN MGA TOP2B | 2.12e-05 | 724 | 111 | 11 | 36232890 |
| Pubmed | 2.81e-05 | 272 | 111 | 7 | 31010829 | ||
| Pubmed | 2.84e-05 | 110 | 111 | 5 | 14667819 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | WDR36 BCLAF1 FBRS DTX3L CLCC1 GANAB LMAN1 DNAJC10 ZNF608 DHFR MORC3 MGA TOP2B SDF2 | 3.01e-05 | 1203 | 111 | 14 | 29180619 |
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 31863478 | ||
| Pubmed | Pancreatic lipase and its related proteins: where are we now? | 3.02e-05 | 3 | 111 | 2 | 38081381 | |
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 25739456 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 32160108 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 22768099 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 1379598 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 9553131 | ||
| Pubmed | Analysis of Expression of the ANG1, CaSR and FAK Proteins in Uterine Fibroids. | 3.02e-05 | 3 | 111 | 2 | 39000274 | |
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 22378044 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 2302735 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 11988077 | ||
| Pubmed | Inhibition of N-glycan processing modulates the network of EDEM3 interactors. | 3.41e-05 | 57 | 111 | 4 | 28366632 | |
| Pubmed | 3.47e-05 | 20 | 111 | 3 | 12560567 | ||
| Pubmed | 4.35e-05 | 198 | 111 | 6 | 24337577 | ||
| Pubmed | RTCB BCLAF1 ACLY OAT EWSR1 MED1 ISY1 GANAB ZNF608 NAT10 SPATS2 CTTN MGA KIF22 | 4.44e-05 | 1247 | 111 | 14 | 27684187 | |
| Pubmed | 4.66e-05 | 22 | 111 | 3 | 24388013 | ||
| Pubmed | 5.21e-05 | 529 | 111 | 9 | 14621295 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | WDR36 RTCB BCLAF1 EWSR1 MED1 ISY1 NSD3 NAT10 RBM6 CTTN MGA TOP2B | 5.55e-05 | 954 | 111 | 12 | 36373674 |
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 25787141 | ||
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 11689006 | ||
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 20305638 | ||
| Pubmed | MAP2K4 NYAP2 BCLAF1 EWSR1 PTK2 NLGN3 NAT10 SPATS2 BSN CTTN MGA TNS1 | 6.07e-05 | 963 | 111 | 12 | 28671696 | |
| Pubmed | Effect of N-(3-phenyl-2-propenyl)-1-deoxynojirimycin on the lectin binding to HIV-1 glycoproteins. | 6.91e-05 | 25 | 111 | 3 | 2283726 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 7.80e-05 | 220 | 111 | 6 | 35785414 | |
| Pubmed | 7.80e-05 | 26 | 111 | 3 | 9339368 | ||
| Pubmed | 7.80e-05 | 26 | 111 | 3 | 8218172 | ||
| Pubmed | WDR36 VWA8 DYNC2H1 BCLAF1 OAT SRPRA CLCC1 MLF2 GANAB LMAN1 DNAJC14 DNAJC10 NAT10 TOP2B SDF2 | 7.82e-05 | 1487 | 111 | 15 | 33957083 | |
| Pubmed | 8.31e-05 | 323 | 111 | 7 | 24797263 | ||
| Pubmed | WDR36 RTCB BCLAF1 EWSR1 CPS1 ISY1 NSD3 NAT10 ZBTB10 SPATS2 TOP2B | 8.69e-05 | 847 | 111 | 11 | 35850772 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 9.29e-05 | 444 | 111 | 8 | 34795231 | |
| Pubmed | 1.00e-04 | 5 | 111 | 2 | 22797919 | ||
| Pubmed | 1.00e-04 | 5 | 111 | 2 | 20643830 | ||
| Pubmed | 1.00e-04 | 5 | 111 | 2 | 17893324 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | WDR36 RTCB BCLAF1 ACLY EWSR1 MLF2 GANAB NAT10 CTTN MGA TOP2B KIF22 | 1.08e-04 | 1024 | 111 | 12 | 24711643 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 1.49e-04 | 608 | 111 | 9 | 36089195 | |
| Pubmed | Structures, alternative splicing, and neurexin binding of multiple neuroligins. | 1.50e-04 | 6 | 111 | 2 | 8576240 | |
| Pubmed | 1.50e-04 | 6 | 111 | 2 | 8810278 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | WDR36 RTCB BCLAF1 ACLY OAT SRPRA EWSR1 ISY1 NSD3 MLF2 NAT10 SPATS2 CTTN | 1.91e-04 | 1257 | 111 | 13 | 36526897 |
| Pubmed | BCL2L14 WDR36 RTCB VWA8 BCLAF1 OAT SRPRA CLCC1 GANAB DNAJC10 NAT10 CTTN TOP2B SDF2 | 2.02e-04 | 1440 | 111 | 14 | 30833792 | |
| Pubmed | 2.10e-04 | 7 | 111 | 2 | 1655359 | ||
| Pubmed | 2.19e-04 | 378 | 111 | 7 | 34315543 | ||
| Pubmed | All kinesin superfamily protein, KIF, genes in mouse and human. | 2.27e-04 | 37 | 111 | 3 | 11416179 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 2.28e-04 | 268 | 111 | 6 | 33024031 | |
| Pubmed | CCZ1B PNLIPRP1 PNLIPRP2 CPS1 MED1 CLCC1 NLGN3 CD101 RPGR DCAF11 TNXB PRLR HCLS1 | 2.50e-04 | 1293 | 111 | 13 | 15342556 | |
| Pubmed | 2.57e-04 | 274 | 111 | 6 | 34244482 | ||
| Pubmed | Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways. | 2.79e-04 | 8 | 111 | 2 | 30871858 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | NRDC RTCB ACLY OAT SRPRA GANAB LMAN1 DNAJC10 CTTN SDF2 SLC27A3 | 2.91e-04 | 974 | 111 | 11 | 28675297 |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 3.21e-04 | 533 | 111 | 8 | 30554943 | |
| Pubmed | Phospho-tyrosine dependent protein-protein interaction network. | 3.57e-04 | 410 | 111 | 7 | 25814554 | |
| Pubmed | 3.58e-04 | 9 | 111 | 2 | 21356198 | ||
| Pubmed | 3.58e-04 | 9 | 111 | 2 | 34919427 | ||
| Pubmed | 3.58e-04 | 9 | 111 | 2 | 20737513 | ||
| Pubmed | 3.58e-04 | 9 | 111 | 2 | 18713744 | ||
| Pubmed | Common variants at 5q22 associate with pediatric eosinophilic esophagitis. | 3.58e-04 | 9 | 111 | 2 | 20208534 | |
| Pubmed | 3.90e-04 | 549 | 111 | 8 | 38280479 | ||
| Pubmed | 4.00e-04 | 551 | 111 | 8 | 34728620 | ||
| Pubmed | Glycosylation and processing of the human immunodeficiency virus type 1 envelope protein. | 4.35e-04 | 46 | 111 | 3 | 2649653 | |
| Pubmed | 4.47e-04 | 10 | 111 | 2 | 19860791 | ||
| Pubmed | Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma. | 4.47e-04 | 10 | 111 | 2 | 22421440 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ACLY GXYLT1 SRPRA EWSR1 CLCC1 SULF2 GANAB LMAN1 DNAJC10 P3H2 SDF2 SLC27A3 | 4.63e-04 | 1201 | 111 | 12 | 35696571 |
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 4.74e-04 | 430 | 111 | 7 | 38172120 | |
| Pubmed | 5.01e-04 | 203 | 111 | 5 | 35012549 | ||
| Pubmed | 5.35e-04 | 206 | 111 | 5 | 22174317 | ||
| Pubmed | 5.45e-04 | 11 | 111 | 2 | 19776009 | ||
| Pubmed | Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. | 5.45e-04 | 11 | 111 | 2 | 19198610 | |
| Pubmed | 5.45e-04 | 11 | 111 | 2 | 32973045 | ||
| Pubmed | 5.52e-04 | 117 | 111 | 4 | 22174793 | ||
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | 5.60e-04 | 580 | 111 | 8 | 35676659 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | NRDC RTCB VWA8 ACLY SRPRA EWSR1 CPS1 ISY1 GANAB DNAJC10 SPATS2 CTTN TOP2B | 5.88e-04 | 1415 | 111 | 13 | 28515276 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | WDR36 NRDC RTCB DYNC2H1 BCLAF1 ACLY OAT GANAB LMAN1 NAT10 BSN CTTN TOP2B | 6.28e-04 | 1425 | 111 | 13 | 30948266 |
| Pubmed | RTCB FBRS EWSR1 GANAB ZNF608 SAMD11 NAT10 ZBTB10 RBM6 ZFHX3 PBX2 CTTN MGA | 6.44e-04 | 1429 | 111 | 13 | 35140242 | |
| Pubmed | Interleukin-33 Promotes Serotonin Release from Enterochromaffin Cells for Intestinal Homeostasis. | 6.52e-04 | 12 | 111 | 2 | 33220232 | |
| Pubmed | XIAP and PHB1 Regulate Anoikis through Competitive Binding to TRAF6. | 6.52e-04 | 12 | 111 | 2 | 36346305 | |
| Pubmed | 6.52e-04 | 12 | 111 | 2 | 20627960 | ||
| Pubmed | MAP2K4 NRDC RTCB BCLAF1 ACLY OAT EWSR1 NHSL1 NLGN3 NRXN2 BSN CTTN TNS1 | 6.53e-04 | 1431 | 111 | 13 | 37142655 | |
| Pubmed | 6.53e-04 | 327 | 111 | 6 | 31409639 | ||
| Pubmed | 6.79e-04 | 457 | 111 | 7 | 22190034 | ||
| Pubmed | Functional genomic landscape of cancer-intrinsic evasion of killing by T cells. | 6.79e-04 | 457 | 111 | 7 | 32968282 | |
| Pubmed | A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. | 6.96e-04 | 331 | 111 | 6 | 19490893 | |
| Pubmed | Novel interactive partners of neuroligin 3: new aspects for pathogenesis of autism. | 6.97e-04 | 54 | 111 | 3 | 25464930 | |
| Pubmed | IKK-Mediated Regulation of the COP9 Signalosome via Phosphorylation of CSN5. | 7.35e-04 | 221 | 111 | 5 | 31950832 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 7.37e-04 | 605 | 111 | 8 | 28977666 | |
| Interaction | SIRT6 interactions | WDR36 BCLAF1 ACLY FBRS TDG MED1 DNAJC10 SAMD11 DHFR NAT10 ZBTB10 RBM6 CTTN TOP2B TRMT61A | 1.64e-06 | 628 | 110 | 15 | int:SIRT6 |
| Cytoband | 7p22.1 | 2.06e-04 | 47 | 111 | 3 | 7p22.1 | |
| Cytoband | 3q13 | 3.14e-04 | 11 | 111 | 2 | 3q13 | |
| Cytoband | 10q25.3 | 2.25e-03 | 29 | 111 | 2 | 10q25.3 | |
| Cytoband | 3q28 | 2.41e-03 | 30 | 111 | 2 | 3q28 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 6.88e-04 | 46 | 68 | 3 | 622 | |
| GeneFamily | Sulfatases | 2.05e-03 | 18 | 68 | 2 | 410 | |
| GeneFamily | T-boxes | 2.05e-03 | 18 | 68 | 2 | 766 | |
| GeneFamily | WD repeat domain containing | 3.05e-03 | 262 | 68 | 5 | 362 | |
| GeneFamily | Solute carriers | 3.66e-03 | 395 | 68 | 6 | 752 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#3_top-relative-expression-ranked_500 | 1.69e-05 | 103 | 111 | 6 | gudmap_developingLowerUrinaryTract_adult_bladder_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_500 | 2.97e-05 | 378 | 111 | 10 | gudmap_developingLowerUrinaryTract_adult_bladder_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_top-relative-expression-ranked_1000 | BCL2L14 FMO2 MYOM1 VWA8 ATP10B DTX3L IDS MAMDC2 LMOD1 RASEF PLAU TNXB TOP2B RAPGEFL1 | 5.18e-05 | 774 | 111 | 14 | gudmap_developingLowerUrinaryTract_P1_ureter_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_500 | PNLIPRP1 PNLIPRP2 KIF26B DTX3L IDS EML5 SETD5 MAMDC2 PBX2 TOP2B | 8.23e-05 | 427 | 111 | 10 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#2_top-relative-expression-ranked_200 | 9.74e-05 | 46 | 111 | 4 | gudmap_developingGonad_e16.5_testes_200_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_1000 | BCL2L14 FMO2 MYOM1 PARP3 ATP10B DTX3L IDS MAMDC2 LMOD1 RASEF PLAU TNS1 TNXB | 1.20e-04 | 734 | 111 | 13 | gudmap_developingLowerUrinaryTract_adult_bladder_1000 |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.28e-08 | 173 | 111 | 8 | 75e26a65071b0d2f30ed0b2aa9859c488f5cf362 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.28e-08 | 173 | 111 | 8 | 26e2e674f5d312fa8f61c11b553dc6101f063b16 | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue-3|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.97e-06 | 174 | 111 | 6 | 7f8f5fafae08676d2b90cab9802c3c9320f1370e | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-Microfold_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.22e-06 | 181 | 111 | 6 | 4d7d367f4ed390908888391335c714a22b5a75c4 | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.84e-06 | 184 | 111 | 6 | 01257e5c12e38b849fd3d9496c43ded666249ba5 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.73e-06 | 188 | 111 | 6 | 8cc927b4c51d982fdafa04dc7393617ad9bb220e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.31e-06 | 110 | 111 | 5 | bc1986e5a496a4d25da3445b6f252f81741619f4 | |
| ToppCell | COVID-19-Myeloid-DC1|COVID-19 / Condition, Lineage and Cell class | 8.46e-06 | 191 | 111 | 6 | 9e44357cdeca46d2b26124bb063c8422ef930083 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.46e-06 | 191 | 111 | 6 | 4e4488380379ed29d7898bae4e24221e7c67eb9d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 8.98e-06 | 193 | 111 | 6 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn|World / Primary Cells by Cluster | 9.80e-06 | 196 | 111 | 6 | 9401bd84798f0ea3e986e94135a9e1dc5643330f | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-B-Plasmablast|ICU-NoSEP / Disease, condition lineage and cell class | 1.01e-05 | 197 | 111 | 6 | 8f35f9741086a38f0e594dce0547b575946f52bb | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.04e-05 | 198 | 111 | 6 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-05 | 198 | 111 | 6 | 12cd9f0bbad8dce5199ebfed1c4a8080710ca055 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.21e-05 | 154 | 111 | 5 | 71d33b5dbfab5820e3daddb01806a69116ba8008 | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.76e-05 | 158 | 111 | 5 | 08806240228c5b780f5aef92ce2c278ae4d797cc | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-05 | 158 | 111 | 5 | 12661763d1c309106801cb710c04cd2b62d16cba | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell-SMC-SMC_Acta2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.76e-05 | 158 | 111 | 5 | 496b6988f7b3439968351840ae22f56ffa1643f1 | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell-SMC|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.76e-05 | 158 | 111 | 5 | 5b3d30f92b619f14a7b48502170000fa5783358a | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-05 | 158 | 111 | 5 | e7db50d6dfaf7280a73a0d5b5aa4f43ea2762d72 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-05 | 158 | 111 | 5 | 0792c39e6fc0745095af7812de2d50949540d60f | |
| ToppCell | Club_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 4.90e-05 | 159 | 111 | 5 | a7bcff268b1962a561fd2848e01ae16565bce895 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-inner_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.20e-05 | 161 | 111 | 5 | 8d2987271da52fd8353557ac6faa4f7a4be0ed2a | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Gad1Gad2-Th.Trh_(Th+_interneuron)|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.09e-05 | 85 | 111 | 4 | 67336aa7ec02b64595ce7d5222d43cead92eb52e | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.09e-05 | 85 | 111 | 4 | a7a5d82924cd4a41ab87b1abf13143635882a4b2 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Gad1Gad2-Th.Trh_(Th+_interneuron)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.09e-05 | 85 | 111 | 4 | 86c5d71b66ff55c44d2d457865dda72e07e5ec53 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.19e-05 | 167 | 111 | 5 | e1b1a952fce27ab9cf16919b290625ff4a75261e | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal|TCGA-Breast / Sample_Type by Project: Shred V9 | 7.52e-05 | 174 | 111 | 5 | e2f240d60bffbe8e6d60f0bb405b231bd3c96875 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.52e-05 | 174 | 111 | 5 | 09b091e24317c3f7bac043f04762a533e30793de | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue|TCGA-Breast / Sample_Type by Project: Shred V9 | 7.52e-05 | 174 | 111 | 5 | 0f3ec0d0d4344e10c9b48adc9174123f6402dc51 | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue|TCGA-Breast / Sample_Type by Project: Shred V9 | 7.52e-05 | 174 | 111 | 5 | 1aadbf2642b6d1320ceabd92e6ff59e11f16c315 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.72e-05 | 175 | 111 | 5 | 59249c9e83952d7277010e7be3c779e26399eb5d | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.72e-05 | 175 | 111 | 5 | b35cc1357495f2a03a6500f807c6e6f8c877734d | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.15e-05 | 177 | 111 | 5 | e55d21d4d61a069b9bbe0e7595fbfb7cfbacfd87 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.15e-05 | 177 | 111 | 5 | 43ba6f12c2fb32698a420bf799d46ac1b558f146 | |
| ToppCell | IIH-matDC|IIH / Condition, Cell_class and T cell subcluster | 8.59e-05 | 179 | 111 | 5 | 5999c85ce3bab5309ff1ed154be7e32b037750b1 | |
| ToppCell | BAL-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 8.59e-05 | 179 | 111 | 5 | 68511e87b12b8253de7771e5ccfc5869248b8450 | |
| ToppCell | facs-Pancreas-Exocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-05 | 179 | 111 | 5 | bbfbfb32773346080127055b5aafa36bbf7d0942 | |
| ToppCell | IIH-matDC-|IIH / Condition, Cell_class and T cell subcluster | 8.59e-05 | 179 | 111 | 5 | 46074b2781ed79e2979428b3ec81504621d3903c | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.05e-05 | 181 | 111 | 5 | 330d4322f4c4373f706273c1f4e218b59051b7fd | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.05e-05 | 181 | 111 | 5 | 3f4d5d79c1286614514b0e8134079d6128a2a23e | |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.29e-05 | 182 | 111 | 5 | 19c5e3a9d9b3728303b682102e276adfe93aa759 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.29e-05 | 182 | 111 | 5 | eb4be1c02b8b033d025e57b8b4cdbfaec4698054 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.78e-05 | 184 | 111 | 5 | 667846c422cfa27e949a24844a305df859cb6760 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 9.78e-05 | 184 | 111 | 5 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.78e-05 | 184 | 111 | 5 | a6f8b42982ec0cf44b950a2cd9715d068eec4ecb | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.00e-04 | 185 | 111 | 5 | 027020754dbf71b0034791f9a34ae795e3b85f81 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-04 | 186 | 111 | 5 | 310d16f4e5cffee3ea6d7635508c513a3b92131e | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 187 | 111 | 5 | f0c6e53035b00772377c4d5f761b4d11026b911a | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.05e-04 | 187 | 111 | 5 | 387cb27c8a20031cd87381a9e1172f1f62e1488b | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.08e-04 | 188 | 111 | 5 | 3004e961d214919e08c7cd5f10c3de5cf85b35a3 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.11e-04 | 189 | 111 | 5 | 98f517af255ef234eefc3ed7e6c1d63331ab8af0 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.11e-04 | 189 | 111 | 5 | f7e9b6e6a4de297b660a5b6c9a62f860c147185e | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.14e-04 | 190 | 111 | 5 | 3b8d1e66ae68c1eee64095e75195d76d97e24026 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.14e-04 | 190 | 111 | 5 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.14e-04 | 190 | 111 | 5 | dc655e4782aab274f0c9b6e36a5ce315e3a1a4b9 | |
| ToppCell | wk_20-22-Endothelial-Lymph_endothelial-Intermediate_lymphatic_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.14e-04 | 190 | 111 | 5 | 103e78c2233c3ee0c215a9dafe70705477e9ee5e | |
| ToppCell | facs-MAT|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 191 | 111 | 5 | b4fba92f9bd1354a07fedfca7304a3757e6d5beb | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.16e-04 | 191 | 111 | 5 | beb5bb42bd53bce01339da9110d374901548793c | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.16e-04 | 191 | 111 | 5 | cd497abed9e00e4e0becd9dbc036c6e7a60ae791 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.16e-04 | 191 | 111 | 5 | 6609d85fd2577633dcc067507304a6f9e5865ca3 | |
| ToppCell | COVID-19-Myeloid-DC1|Myeloid / Condition, Lineage and Cell class | 1.16e-04 | 191 | 111 | 5 | 4be3c6287965fe3a2f109d26f68bdc2fa393f99b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.19e-04 | 192 | 111 | 5 | 0b954a4e5857dac45d97c491af9b27cb2d1bd339 | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 1.19e-04 | 192 | 111 | 5 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 1.19e-04 | 192 | 111 | 5 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | PBMC-Control-cDC_6|Control / Compartment, Disease Groups and Clusters | 1.19e-04 | 192 | 111 | 5 | 41a7201febb7d88a39e4ee64df04cce18c691df8 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.22e-04 | 193 | 111 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.22e-04 | 193 | 111 | 5 | 96c85b250d04b5f400512097d925061c6dc2906b | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 1.22e-04 | 193 | 111 | 5 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 1.22e-04 | 193 | 111 | 5 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Mesenchymal-mesenchymal_stem_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 193 | 111 | 5 | 160691b671710be10220803d788c2c961c236af1 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-22|World / Primary Cells by Cluster | 1.22e-04 | 193 | 111 | 5 | 3b927d4b8ecb21a408424ef91a23746c21741f49 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Paneth|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-04 | 194 | 111 | 5 | 2f6e62a4ec8707bd5a16c0734c5131af55207ea2 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.25e-04 | 194 | 111 | 5 | 8fae8061b350336299aa81f378e07deadbd55123 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 194 | 111 | 5 | bf34737ae2dc218f890fbb9201c308b324415749 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.25e-04 | 194 | 111 | 5 | 69362e13158033de44f90f3773db6c0f27de8cb3 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.25e-04 | 194 | 111 | 5 | 4d7d24390fdb379f943ddcc70a63f23955e10163 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 194 | 111 | 5 | b35e33439b6d3b5d69147e617224d2c8fd056223 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 194 | 111 | 5 | 4ebed7a6731b88c8359860072cbeba355a7e90ac | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.28e-04 | 195 | 111 | 5 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.28e-04 | 195 | 111 | 5 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.28e-04 | 195 | 111 | 5 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.28e-04 | 195 | 111 | 5 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.28e-04 | 195 | 111 | 5 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | ILEUM-non-inflamed-(8)_Pericytes|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.31e-04 | 196 | 111 | 5 | b98fe1519e420d8b03c66e164bf4544f3dbb2e44 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.31e-04 | 196 | 111 | 5 | f374cb3ec31c6eef2cef9e07547bfd1e380553af | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.31e-04 | 196 | 111 | 5 | 671c380b58d7f634b4fbec38c357d357ea4f3535 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-04 | 196 | 111 | 5 | 1bcae4e0a244af822e2b12b2026a2771316f107d | |
| ToppCell | proximal-mesenchymal-Myofibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.35e-04 | 197 | 111 | 5 | ab21baea931ff134cf5a7ee369c091230988108b | |
| ToppCell | proximal-mesenchymal-Myofibroblast-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.35e-04 | 197 | 111 | 5 | 15f2f169758a07143fc7d1bdb58d0b4d750a0be4 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Mesofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-04 | 197 | 111 | 5 | d7cef7881abd807a679432766ced609a6efd1067 | |
| ToppCell | proximal-3-mesenchymal-Myofibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.35e-04 | 197 | 111 | 5 | c59b64674fb4aaa945c1df7e4a9a3605c7cd2b75 | |
| ToppCell | (3)_Chondrocytes-(34)_Chondro-progen|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.35e-04 | 197 | 111 | 5 | 012c49a57f9c2a3dfa988cd3882c8c6b7ef3a5ad | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.35e-04 | 197 | 111 | 5 | 16758f181ef07c60aee63072e1da9572c5c85414 | |
| ToppCell | distal-Hematologic-IGSF21+_Dendritic|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.35e-04 | 197 | 111 | 5 | a357ee2ba9100dfaeba9ecae8138a2776bb54b0b | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-04 | 197 | 111 | 5 | 20a5958512bdb99daeb8f4d244df53e4f048f879 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.35e-04 | 197 | 111 | 5 | bf10727fbe90b71d2ac60a11711e5f0701b3799d | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.35e-04 | 197 | 111 | 5 | b7e399b8e1a1ffc2b359f14929f199b93d9bbcce | |
| ToppCell | COVID-19-Myeloid-Migratory_DC|COVID-19 / Condition, Lineage and Cell class | 1.35e-04 | 197 | 111 | 5 | b6d6cdae33753c1e38394f1f879e00b87f9c0496 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Pericytes|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.38e-04 | 198 | 111 | 5 | 5e274c5597d8720290d452465f0bd40637cb3f27 | |
| Disease | FEV/FEC ratio | MAP2K4 PTK2 MLF2 LMOD1 ZFHX3 PLAU PBX2 CTTN MGA TNS1 MN1 TNXB TOP2B JPH3 RAPGEFL1 | 3.32e-05 | 1228 | 106 | 15 | EFO_0004713 |
| Disease | Nystagmus | 5.72e-05 | 21 | 106 | 3 | HP_0000639 | |
| Disease | xanthosine measurement | 9.78e-05 | 25 | 106 | 3 | EFO_0010549 | |
| Disease | bitter alcoholic beverage consumption measurement | 1.21e-04 | 133 | 106 | 5 | EFO_0010092 | |
| Disease | leiomyoma (is_implicated_in) | 1.90e-04 | 6 | 106 | 2 | DOID:127 (is_implicated_in) | |
| Disease | prostate cancer (is_marker_for) | 2.55e-04 | 156 | 106 | 5 | DOID:10283 (is_marker_for) | |
| Disease | Endometrioma | 2.95e-04 | 161 | 106 | 5 | C0269102 | |
| Disease | Endometriosis | 2.95e-04 | 161 | 106 | 5 | C0014175 | |
| Disease | cortical surface area measurement | NYAP2 KIF26B PRSS12 CPS1 NHSL1 MLF2 SULF2 DHFR ZFHX3 TNS1 TNXB PRLR TRMT61A EPHB1 | 3.28e-04 | 1345 | 106 | 14 | EFO_0010736 |
| Disease | hepatocyte growth factor-like protein measurement | 3.47e-04 | 38 | 106 | 3 | EFO_0008154 | |
| Disease | Inhalant adrenergic use measurement | 4.05e-04 | 96 | 106 | 4 | EFO_0009941 | |
| Disease | phosphatidylcholine measurement | 5.75e-04 | 284 | 106 | 6 | EFO_0010226 | |
| Disease | blood nickel measurement | 9.39e-04 | 120 | 106 | 4 | EFO_0007583 | |
| Disease | myeloid leukemia (is_implicated_in) | 9.72e-04 | 13 | 106 | 2 | DOID:8692 (is_implicated_in) | |
| Disease | Hermansky-Pudlak syndrome (implicated_via_orthology) | 1.13e-03 | 14 | 106 | 2 | DOID:3753 (implicated_via_orthology) | |
| Disease | urolithiasis | 1.53e-03 | 63 | 106 | 3 | MONDO_0024647 | |
| Disease | asthma | 1.56e-03 | 751 | 106 | 9 | MONDO_0004979 | |
| Disease | neuritic plaque measurement | 1.66e-03 | 349 | 106 | 6 | EFO_0006798 | |
| Disease | Antihistamine use measurement | 1.68e-03 | 17 | 106 | 2 | EFO_0009943 | |
| Disease | breast size | 1.99e-03 | 69 | 106 | 3 | EFO_0004884 | |
| Disease | Craniosynostosis | 2.33e-03 | 20 | 106 | 2 | C0010278 | |
| Disease | serum homoarginine measurement | 2.33e-03 | 20 | 106 | 2 | EFO_0005421 | |
| Disease | citrulline measurement | 2.33e-03 | 20 | 106 | 2 | EFO_0009777 | |
| Disease | pentachlorophenol measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022071 | |
| Disease | parathion measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022070 | |
| Disease | potassium chromate measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022072 | |
| Disease | mercuric chloride measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022068 | |
| Disease | heptachlor epoxide measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022067 | |
| Disease | methoxychlor measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022069 | |
| Disease | 4,6-dinitro-o-cresol measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022053 | |
| Disease | 2,4,5-trichlorophenol measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022052 | |
| Disease | azinphos methyl measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022055 | |
| Disease | aldrin measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022054 | |
| Disease | dicofol measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022060 | |
| Disease | disulfoton measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022062 | |
| Disease | dieldrin measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022061 | |
| Disease | endrin measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022064 | |
| Disease | endosulfan measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022063 | |
| Disease | heptachlor measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022066 | |
| Disease | ethion measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022065 | |
| Disease | chlorpyrifos measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022057 | |
| Disease | cadmium chloride measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022056 | |
| Disease | diazinon measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022059 | |
| Disease | dibutyl phthalate measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0022058 | |
| Disease | environmental exposure measurement | 2.33e-03 | 73 | 106 | 3 | EFO_0008360 | |
| Disease | DDT metabolite measurement | 2.43e-03 | 74 | 106 | 3 | EFO_0007886 | |
| Disease | Autistic Disorder | 2.56e-03 | 261 | 106 | 5 | C0004352 | |
| Disease | alcohol consumption measurement, high density lipoprotein cholesterol measurement | 2.82e-03 | 162 | 106 | 4 | EFO_0004612, EFO_0007878 | |
| Disease | Asthma | 3.03e-03 | 80 | 106 | 3 | C0004096 | |
| Disease | chronic widespread pain | 3.08e-03 | 23 | 106 | 2 | EFO_0010099 | |
| Disease | insulin sensitivity measurement | 3.08e-03 | 23 | 106 | 2 | EFO_0004471 | |
| Disease | creatinine measurement | 3.12e-03 | 995 | 106 | 10 | EFO_0004518 | |
| Disease | alcohol drinking, high density lipoprotein cholesterol measurement | 3.21e-03 | 168 | 106 | 4 | EFO_0004329, EFO_0004612 | |
| Disease | nighttime rest measurement | 3.35e-03 | 24 | 106 | 2 | EFO_0007827 | |
| Disease | body fat percentage, coronary artery disease | 3.35e-03 | 24 | 106 | 2 | EFO_0001645, EFO_0007800 | |
| Disease | low density lipoprotein cholesterol measurement, response to escitalopram, response to citalopram | 3.35e-03 | 24 | 106 | 2 | EFO_0004611, EFO_0006329, EFO_0007871 | |
| Disease | phosphatidylethanolamine measurement | 3.56e-03 | 173 | 106 | 4 | EFO_0010228 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MDDHTLPGKYGIGFT | 176 | Q13569 | |
| HPSSMGVYGQESGGF | 271 | Q01844 | |
| PTGIYGEGHQIMRDF | 191 | Q9H2F3 | |
| AMPQYFHVVGGTIGF | 306 | P41180 | |
| DNHPMNRVLGFGTKY | 286 | Q9BZR8 | |
| IGGYLFGSKGFHPMV | 101 | Q15782 | |
| QLGCGKPLHVFGMTY | 516 | Q9NR16 | |
| KTLHPGGMAEGGYFF | 166 | Q8WUJ3 | |
| KGYMEHPDQTRTGFG | 251 | O94823 | |
| GAYGSVNKMVHKPSG | 111 | P45985 | |
| PGHFGEKLAMTYGAL | 671 | Q8IZ41 | |
| IMPHSGGRVGKGIYF | 401 | Q9Y6F1 | |
| ERMGQSDFGAGHYPQ | 1796 | Q8WYB5 | |
| KPNMYRAGDHTTGLG | 366 | Q7Z304 | |
| HYSTGRGSPGMKIYI | 581 | P54762 | |
| YGEDMGHPGSRKFNT | 12401 | Q8WXI7 | |
| MAQKHPGERGLYGAH | 1 | Q6Y2X3 | |
| HQAYFGEGSGPVMLD | 331 | P56730 | |
| TMAYFGEGKGPIHVD | 551 | P56730 | |
| QVESLRHSMGPGGYG | 371 | P40425 | |
| GGLVDMGGSKYPHEV | 2661 | Q8IWI9 | |
| MLDHEGKEVPGNRGY | 106 | Q9ULR0 | |
| PAMGKTALFYHSGGS | 1881 | Q2KJY2 | |
| YDPRGKGGHLRSMES | 3296 | Q9UPA5 | |
| AGDMNGTFLYQRGHP | 351 | Q5SYE7 | |
| GYHFELAGPRMTVTN | 451 | P29536 | |
| GCPQMGHYADKFAGR | 321 | P54315 | |
| MNGHVPVGLYGNGFK | 91 | Q14149 | |
| YIYESGGPGHSKMTE | 441 | Q9UHC1 | |
| YGPTGAGKTHTMLGS | 126 | Q14807 | |
| KLPGDSSLMTYRGHG | 421 | Q8TEB1 | |
| YKHTGGEIGLMPCFD | 961 | Q5H8C1 | |
| RHPYYGKTGVNSGVM | 261 | Q4G148 | |
| HYVFDLGNGPSLMKG | 976 | Q9P2S2 | |
| GAGKTYTMIGTHENP | 316 | Q5T7B8 | |
| LVSGMQHPGSAGGVY | 416 | P49257 | |
| SSRFQYHMVIAPGKG | 101 | Q9H3R1 | |
| RGHEGSYVGKHFRMG | 81 | Q9P242 | |
| IMLVGDGYRGKTSPH | 486 | Q8IVL5 | |
| VGKHFTVVDMPGYGF | 156 | Q8N3Z3 | |
| VHPDYQGMGYGSRAL | 631 | Q9H0A0 | |
| DSGAKPVMVYIHGGS | 196 | Q9NZ94 | |
| MHGAVLFSPKISRGY | 2671 | Q8NCM8 | |
| MKGYSFGHPSSVAGE | 56 | P31327 | |
| PGKMEGLFRHNPYTA | 6 | Q9HAH7 | |
| GVPSYHGNTRLEKMD | 476 | Q93033 | |
| IHHKTSRFGGPEMYG | 706 | Q8TDB6 | |
| HEMKEYSGFAGVSRP | 781 | Q9NYF8 | |
| VGGSSVYKEAMNHPG | 116 | P00374 | |
| EMPGNLQHYGRFLTG | 271 | P86791 | |
| EMPGNLQHYGRFLTG | 271 | P86790 | |
| LVHFPPGDSYGMQGS | 421 | Q9NTJ4 | |
| DGKYLVTGESGHMPA | 101 | O60336 | |
| PGMERFKGQYFHSRQ | 161 | Q99518 | |
| ARAKAPSRMYGGHGS | 826 | Q32P44 | |
| HNGPVFAMYTTLRDG | 1601 | Q05BV3 | |
| NGYVTMSVGKVFHPG | 126 | P22304 | |
| IFRSGMAPVKYHGDR | 206 | Q8IXB1 | |
| MYKGIGASYFRLGPH | 266 | Q3KQZ1 | |
| GSVGYLTPRSGGHLM | 206 | Q15648 | |
| MSQKVGHLDFFPNGG | 236 | P54317 | |
| HMSRMLSGGFGYSPF | 26 | Q15773 | |
| LGMNMEPYGFHARGH | 61 | Q10571 | |
| TDIGLMYTFGDGRHG | 311 | Q92834 | |
| QGYFLQMHPDGTIDG | 81 | P61328 | |
| PDVHSGYGFAIGNMA | 86 | Q9Y3I0 | |
| HRLPGSQMFGYGQSK | 411 | P78332 | |
| KNRTGPMGHTYGFID | 691 | P78332 | |
| HFYRGKASTDTMGRP | 76 | P00749 | |
| HGGKDAASPRYIFTM | 816 | Q02880 | |
| KEMESGPKASHGYGG | 71 | P14317 | |
| TGISYGMGLKHRFEV | 306 | Q9BXS9 | |
| HGITAMAGSIYPGQA | 751 | Q05397 | |
| GPEVTMLKDAQHYGG | 551 | Q14697 | |
| AFGERQYLPSGMEHS | 551 | Q96SF7 | |
| DHYGRKFPMILSSVG | 96 | Q7Z3Q1 | |
| PAEGFSSRYEHGLMK | 1021 | Q9C0A6 | |
| SEYESPFMGGARGHA | 131 | Q9BRY0 | |
| SPYFHTGAVGGLSMD | 516 | Q96NU1 | |
| GSVDGHMKLYRAVNP | 261 | Q9H1D9 | |
| MLTIKPGEHGSTYGG | 311 | P04181 | |
| PGHGKVMVDIAYGGA | 176 | Q96EM0 | |
| YGRPISGQKEVHGMA | 166 | Q99470 | |
| AIGGDRYPGSTFMDH | 686 | P53396 | |
| NGEPMRFGHVYMGNS | 501 | O75339 | |
| ADFHYRGQMGPTEQG | 396 | Q96S66 | |
| YHSGKFMPAGLIAGA | 81 | Q9P0S9 | |
| APSSEKGGMNGYHVN | 121 | Q86XZ4 | |
| YPNKPRSGGMLFHIF | 1006 | O75762 | |
| YGVTVPGHEGRAGMA | 576 | Q5K4L6 | |
| SHGYGGKFGVEQDRM | 81 | Q14247 | |
| RSHYKPEQMGKDGRG | 626 | P42226 | |
| RSGTPMKEAVGHTGY | 266 | Q96FX7 | |
| YGFHGGQRMGPVSVV | 2056 | P22105 | |
| GFGLEREKQGAMYHT | 446 | Q9HBL0 | |
| CISMEGKIPYFHAGG | 396 | P16471 | |
| RGPGSKMLSVHVVGY | 1076 | O43847 | |
| HGGRTMVQLFEKGYG | 481 | P08240 | |
| DAGPKGNYSRFMNHS | 1211 | Q9BZ95 | |
| GFIHTGMEPYGDSQC | 226 | Q2M218 | |
| GFHYPVYGKMSGREE | 1381 | Q9ULD9 | |
| PAHEVTGSGGAYMRF | 311 | Q7RTT9 | |
| GDAGTSHDFKYGLMP | 651 | Q96DT7 | |
| ELHQYFVRAGGMEGP | 196 | Q9UHV5 | |
| VGHSGDGYNIGLVPM | 1761 | A3KMH1 | |
| NLRRHMVVKGGDGPY | 231 | P15621 | |
| HIGQFGLVKGKSMPY | 321 | Q8IWU5 | |
| LNGGKYSFGTAAHPM | 426 | Q8NFA0 | |
| GEPYRLMTASGTHGR | 81 | Q9H354 | |
| GHSFYGKFSGIRMEG | 361 | Q15911 | |
| YNMQSGIHRGSFGKD | 521 | Q8NI36 | |
| HGYGCMTFPDGTKEE | 321 | Q8WXH2 | |
| TGGGSRELYMRHFPF | 116 | Q96L15 | |
| YMVPIFSGRQKHVSG | 136 | P52179 | |
| PGQRGHEGIMYFVEK | 661 | P52179 |